ASEPA EXCLUSIVE WEBINARS:
Can't attend an event live? You will be able to access webinar online and claim CME credit (if available) for up to one year past webinar date by visiting this website. For those webinars which have an evaluation, you will receive your CME certificate by email soon after submitting the evaluation.
​
​
​​
​​
*Unless otherwise noted, all webinars are at 8 PM EST​​​​​
​​
-
October 22, 2024 - An Update On Finerenone Beyond CKD and Type 2 DM by Maria O'Connor, PA-C, RD, CDCES (non-CME)​​
Zoom link: https://us02web.zoom.us/j/89289347914
-
November 12, 2024 - Hypophosphatasia (non-CME)
-
December 3, 2024 - Catalyst trial results (non-CME)
UPCOMING WEBINARS:
PREVIOUS WEBINARS:
-
September 2024 - ASEPA Case Studies: Clinical cases of Type 3c Diabetes and MODY by Katharine Patrick, MMSc, PA-C and Amy Hess Fischl, MS, RDN, LDN, BC-ADM, CDCES
​ - Enduring CME evaluation
-
August 2024- Celiac Disease by Alyssa Greenleaf, MHS, PA-C
- Enduring CME evaluation​
- Enduring CME evaluation​
-
​June 2024- Bempedoic Acid by Michelle Lim, PA-C (non-CME)​
-
May 2024- Cardiometabolic Health Congress Certification by Robert Eckel, MD (non-CME)
-
April 2024- Immune Checkpoint Inhibitors by Justine Herndon, PA-C
- Enduring CME evaluation​
-
​March 2024- BD-ADM Certification by Chris Memering, CDCES (non-CME)​
-
February 2024- Osteoporosis by Jacqui Kernaghan, PA-C
-
January 2024- An update on the June 2023 Adrenal Incidentaloma Guidelines by CJ Chun, PA-C (non- CME)
-
December 2023- Endocrine Work-up of Obesity ​
-
November 2023 - Obesity Pathogenesis & Treatment
- Enduring CME evaluation
-
October 2023 - PA Professional Development Panel Discussion (non-CME)
-
September 2023 - Tzield (non-CME)
-
August 2023 - Endocrine Hypertension
- Enduring CME Evaluation -
July 2023 - SGLT2 inhibitors
- Enduring CME Evaluation -
June 2023 - PTH-mediated Hypercalcemia
- Enduring CME Evaluation -
May 2023 - Diabetes Technology
- Enduring CME Evaluation -
April 2023 - Dexcom (non-CME ) (video unavailable)
-
March 2023 - PANRE Alternative
- Enduring CME Evaluation -
February 2023 - Afrezza (non-CME) (video unavailable)
-
January 2023 - no webinar
​
​
​
2022 Webinars:
-
December 2022 - Updates and Tips for Success Using FS Libre 2 and 3 (non-CME)
-
November 2022 - Pheochromocytomas and Paragangliomas
- Enduring CME Evaluation -
October 2022 - Tandem Pumps and T connect reports
-
September 2022 - Mounjaro (non-CME) (video unavailable)
-
August 2022 - Wegovy (non-CME) and OmniPod 5 (non-CME)
-
July 2022 - Hypercalcemia of Malignancy
-
June 2022 - no webinar
-
May 2022 - Central Hyperthyroidism
-
April 2022 - Slowing the Development of Autoimmune Diabetes (video unavailable)
-
March 2022 - Gender Affirming Hormone Therapy: The Basics and Beyond - Troubleshooting Complications and Hot Topics
-
Feb 2022 - Dexcom Connected Ecosystems and Partnerships
-
January 2022 - no webinar
​
2021 Webinars:
​
-
Dec 2021 - Omega-3 fatty acids and hypertriglyceridemia
-
Oct 2021 - Pituitary Tumor Series Part 1 - Workup of Sellar Masses
-
Sept 2021 - Gvoke: Treatment of Severe Hypoglycemia
-
August 2021 - Management of Type 1 DM in pregnancy
-
July 2021 - Acromegaly
-
June 2021 - Cushing's Syndrome
-
May 2021 - SGLT2i in setting of DM and CKD (non-CME)
-
April 2021 - Osteoporosis
-
March 2021 - Adrenal Incidenalomas (non-CME)
-
Feb 2021 - PAs and Clinical Research
-
Jan 2021 - V-go
​
2020 Webinars:
​
-
Dec 2020 - CGM Therapy - What's New
​
​​​
2019 Webinars:
​
-
Nov 2019 - Using CGM Data Effectively
​
​